DreamCIS, Inc. (KOSDAQ:223250)
South Korea · Delayed Price · Currency is KRW 6,930.00
-490.00 (-6.60%)
At close: May 14, 2026
DreamCIS Market Cap
DreamCIS has a market cap or net worth of 161.62 billion as of May 15, 2026. Its market cap has increased by 134.99% in one year.
Market Cap
161.62B
Enterprise Value
150.92B
Revenue
66.63B
Ranking
n/a
PE Ratio
22.05
Stock Price
6,930.00
Market Cap Chart
Since May 22, 2020, DreamCIS's market cap has decreased from 165.28B to 161.62B, a decrease of -2.21%. That is a compound annual growth rate of -0.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 170.48B | 12.28% |
| Dec 30, 2025 | 151.84B | 116.27% |
| Dec 30, 2024 | 70.21B | -9.03% |
| Dec 28, 2023 | 77.17B | 25.17% |
| Dec 29, 2022 | 61.65B | -15.87% |
| Dec 30, 2021 | 73.28B | -32.30% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| May 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 474.25B |
| HLB bioStep | 107.65B |
| P&K Skin Research Center | 67.44B |
| WOOJUNG BIO | 49.82B |
| C&R Research | 39.42B |
| DT&CRO CO. | 37.07B |
| SLS BIO | 26.89B |
| BioInfra | 19.43B |